Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Duration of supervised exercise necessary for meaningful improvement in peripheral artery disease [with consumer summary]
McDermott MM, Zhang D, Zhao L, Polonsky T, Ferrucci L, Ho KJ, Kibbe MR, Guralnik JM, Criqui MH, Tian L
Journal of the American Heart Association 2025 Sep 16;14(18):e040058
clinical trial
This trial has not yet been rated.

BACKGROUND: Supervised treadmill exercise improves walking performance in people with lower extremity peripheral artery disease, but benefits are not immediate. This study identified the time course of attaining meaningful improvement in 6-minute walk distance and patient-reported outcome measures during a 6-month supervised exercise intervention in people with peripheral artery disease. METHODS: Participants with peripheral artery disease were randomized to supervised treadmill exercise 3 time weekly or a nonexercise control group for 6 months. Six-minute walk distance (large clinically important difference 20 meters) and the Walking Impairment Questionnaire distance score (0 to 100 scale, 100 is best, clinically important difference 5 points) were measured at the 6-week, 12-week, and 26-week follow-up using a mixed-effects model for repeated measures. RESULTS: Of 210 randomized participants (mean age 67.0 +/- 8.6 years, 82 (39%) women, 141 (66%) Black), 200 (95%) completed at least 1 follow-up visit. Compared with controls, supervised exercise significantly improved 6-minute walk distance by 13.0 m (p = 0.049) at the 6-week, 31.8 m (p < 0.001) at the 12-week, and 33.9 m (p < 0.001) at the 26-week follow-up. Compared with controls, supervised exercise increased the Walking Impairment Questionnaire distance score by +2.63 (p = 0.37) at the 6-week, +6.59 (p = 0.049) at the 12-week, and +2.37 (p = 0.49) at the 26-week follow-up. CONCLUSIONS: In people with peripheral artery disease, > 6 weeks of supervised treadmill exercise was necessary to attain a large meaningful gain in 6-minute walk, and large meaningful gains were measurable by week 12 of supervised exercise. Meaningful improvement in participant reported walking ability was first observed at the 12-week follow-up, but this statistically significant benefit was gone by the 26-week follow-up. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01408901.

Full text (sometimes free) may be available at these link(s):      help